Patent Assignment
Reel/Frame 046755/0896
Assignment of Assignor's Interest
Recorded: 2018-08-30
Pages: 3
Assignors
RIVERA, DANIEL S.
Executed: 2004-11-08
PETERS, ROBERT T.
Executed: 2004-10-06
BITONTI, ALAN J.
Executed: 2004-10-06
Assignee
SYNTONIX PHARMACEUTICALS, INC.
9 FOURTH AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Property
(1)
Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
Application:
15/866,203 →
Publication:
US 2018/0237762
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Aug 30, 2018
From: BIOGEN IDEC HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 046986/0510 →
Change of Name
Aug 30, 2018
From: BIOGEN HEMOPHILIA INC.
To: BIOVERATIV THERAPEUTICS INC.
Reel/Frame 046986/0546 →
Change of Address
Aug 30, 2018
From: BIOGEN HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 046986/0653 →
Change of Name
Aug 30, 2018
From: SYNTONIX PHARMACEUTICALS, INC.
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 046986/0674 →